The present invention provides an imidazo[4,5-c]quinolin-2-one compound, or a pharmaceutically acceptable salt thereof, that inhibits both PI3K and mTOR and, therefore, is useful in the treatment of cancer.
-
Page/Page column 4
(2012/07/28)
More Articles about upstream products of 1386874-30-1